These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16525667

  • 1. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2.
    Zhang A, Meng L, Wang Q, Xi L, Chen G, Wang S, Zhou J, Lu Y, Ma D.
    Oncol Rep; 2006 Apr; 15(4):831-6. PubMed ID: 16525667
    [Abstract] [Full Text] [Related]

  • 2. [Role of vascular endothelial growth factor overexpression in ovarian tumor invasion and mechanism].
    Lu Y, Zhang A, Wang S, Li J, Wang C, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):294-7. PubMed ID: 12133405
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of expression of vascular endothelial growth factor and matrix matalloproteinase-2 to invasion of ovarian tumor cells in vitro].
    Zhang AL, Wang SX, Lu YP, Li J, Wang CY, Ma D.
    Ai Zheng; 2002 Mar; 21(3):263-6. PubMed ID: 12451991
    [Abstract] [Full Text] [Related]

  • 4. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW, Leung PC, Wong AS.
    Cancer Res; 2006 Nov 15; 66(22):10902-10. PubMed ID: 17108127
    [Abstract] [Full Text] [Related]

  • 5. [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells].
    Hu XX, Li L, Li DR, Zhang W, Tang BJ.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 15; 28(9):662-5. PubMed ID: 17274370
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
    Zhuang ZG, Di GH, Hou YF, Liu G, Luo JM, Shen ZZ, Shao ZM.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 09; 87(2):81-4. PubMed ID: 17418010
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.
    Oncol Rep; 2003 Jan 09; 10(1):89-95. PubMed ID: 12469150
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
    Wu M, Xu G, Xi L, Wei J, Song A, Han Z, Zhou J, Wang S, Zhu T, Zhang A, Lu Y, Ma D.
    Oncol Rep; 2006 Feb 09; 15(2):501-5. PubMed ID: 16391876
    [Abstract] [Full Text] [Related]

  • 9. [Inhibitory effect of AG490 on invasion and metastasis of human pancreatic cancer cells in vitro].
    Huang C, Qiu ZJ, Cao J, Huang KJ, Zhang F, Jiang T, Zhu L, Liu J.
    Zhonghua Zhong Liu Za Zhi; 2006 Dec 09; 28(12):890-3. PubMed ID: 17533737
    [Abstract] [Full Text] [Related]

  • 10. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
    Zhao Y, Zong ZH, Xu HM.
    Gynecol Oncol; 2010 Mar 09; 116(3):563-71. PubMed ID: 20022093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells].
    Hu XX, Li L, Li DR, Zhang W, Tang BJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep 09; 41(9):579-83. PubMed ID: 17181964
    [Abstract] [Full Text] [Related]

  • 13. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
    Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R.
    Cancer Res; 2006 Nov 01; 66(21):10357-64. PubMed ID: 17079456
    [Abstract] [Full Text] [Related]

  • 14. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang X, Zheng X, Mikkelsen T, Jiang H, Chopp M.
    J Exp Ther Oncol; 2007 Nov 01; 6(3):219-29. PubMed ID: 17552362
    [Abstract] [Full Text] [Related]

  • 15. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL, Zhang SL, Lu YM, Jiang JY, Zhu XY.
    Ai Zheng; 2006 May 01; 25(5):570-5. PubMed ID: 16687076
    [Abstract] [Full Text] [Related]

  • 16. [Effects of follicle stimulating hormone on proliferation, apoptosis, migration and invasion of ovarian carcinoma cells: an in vitro experiment].
    Huang Y, Zhao YQ, Su M, Gao SJ, Jin HY, Feng YJ.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2512-4. PubMed ID: 18067819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J, Wang B.
    Gynecol Oncol; 2006 Oct 18; 103(1):199-206. PubMed ID: 16624393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.